Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2023

Open Access 01-12-2023 | Cervical Cancer | Research

A population-based cross-sectional study on the situation of cervical cancer screening in Liaoning, China

Authors: Bo Zhu, Huihui Yu, Ping Ni, Xi Chen, Jing Zhang, Danbo Wang

Published in: BMC Women's Health | Issue 1/2023

Login to get access

Abstract

Background

Cervical cancer (CC) screening is currently recognized as an effective intervention for CC. Previous studies found that the proportion of screening was low in China, especially in Liaoning. Therefore, we performed a population-based cross-sectional survey to investigate the situation of cervical cancer screening and analyze their related factors for providing a decision-making basis for sustainable and effective development of cervical cancer screening.

Methods

This population-based cross-sectional study involved aged 30 to 69 years in nine counties/districts in Liaoning from 2018 to 2019. Data were collected using the quantitative data collection methods, and analyzed in SPSS version 22.0.

Results

Overall, only 22.37% of 5334 respondents reported having ever been screened for cervical cancer in past 3 years, and 38.41% of respondents reported having the willingness for cervical cancer screening in next 3 years. In the rate of CC screening, multilevel analysis indicated that age, marital status, education level, type of occupation, medical insurance, family income, place of residence and regional economic level had a significant impact on proportion of screening. In the rate of CC screening willingness, multilevel analysis indicated that age, family income, health status, place of residence, regional economic level and CC screening still had a significant impact, but marital status, education level and medical insurance type had no significant impact. There was no significant difference in marital status, education level and medical insurance type after the factors of CC screening were added in the model.

Conclusion

Our study found both proportion of screening and willingness were at a low level, and age, economic and regional factors were the main factors for implementation of CC screening in China. In the future, targeted policies should be formulated according to the characteristics of different groups of people, and reduce the gap in the current health service capacity between different regions.
Literature
1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
Chen W, Sun K, Zheng R, Zhang S, Zeng H, Zhou X, He J. Report of Cancer incidence and mortality in different areas of China, 2014. China Cancer. 2018;27(01):1–14.
3.
Sun K, Zheng R, Zhang S, Zeng H, Zhou X, Chen R, Gu X, Wei W, He J. Report of Cancer incidence and mortality in different areas of China, 2015. China Cancer. 2019;28(01):1–11.
4.
Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319–21.CrossRefPubMed
5.
Xia C, Hu S, Xu X, Zhao X, Qiao Y, Broutet N, Canfell K, Hutubessy R, Zhao F. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. The Lancet Public health. 2019;4(9):e462–72.CrossRefPubMed
6.
7.
Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet (London England). 2019;393(10175):969–70.CrossRefPubMed
8.
Lu H, He H, Qin J, Chen M, Liu Q, Li M, Huang Y, Wei A, Liu S, Xu M, et al. Populations at high risk of cervical cancer in Guangxi Province: findings from two screening projects in a minority area of South China. J Med Screen. 2022;29(1):44–52.CrossRefPubMed
9.
Landy R, Birke H, Castanon A, Sasieni P. Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years. Br J Cancer. 2014;110(7):1841–6.CrossRefPubMedPubMedCentral
10.
Guan P, Huang D, Guo J, Wang P, Zhou B. Bacillary dysentery and meteorological factors in northeastern China: a historical review based on classification and regression trees. Jpn J Infect Dis. 2008;61(5):356–60.CrossRefPubMed
11.
Fang W, Xu X, Zhu Y, Dai H, Shang L, Li X. Impact of the National Health Insurance Coverage Policy on the Utilisation and accessibility of innovative anti-cancer Medicines in China: an interrupted time-series study. Front public health. 2021;9:714127.CrossRefPubMedPubMedCentral
12.
Bao H, Zhang L, Wang L, Zhang M, Zhao Z, Fang L, Cong S, Zhou M, Wang L. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med. 2018;7(5):2089–100.CrossRefPubMedPubMedCentral
13.
Mu H, Li Y, Yu L, Li S, Zhang L, Na J, Ma X, Pan G, Liu L. Trend of Incidence and Mortality in Five Cities of Liaoning Province from 2006 to 2015.China Cancer:1–8.
14.
Wallington SF, Luta G, Noone AM, Caicedo L, Lopez-Class M, Sheppard V, Spencer C, Mandelblatt J. Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos. J Community Health. 2012;37(2):335–43.CrossRefPubMedPubMedCentral
15.
Global regional. National age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet (London England). 2015;385(9963):117–71.CrossRef
16.
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al. The global burden of Cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRefPubMed
17.
Hemminki K, Kanerva A, Försti A, Hemminki A. Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment. BMC Cancer. 2022;22(1):456.CrossRefPubMedPubMedCentral
18.
WHO. : Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva: © World Health Organization 2014.; 2014.
19.
Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, Daye JL, Castle PE. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116(11):2531–42.PubMed
20.
Richard A, Rohrmann S, Schmid SM, Tirri BF, Huang DJ, Güth U, Eichholzer M. Lifestyle and health-related predictors of cervical cancer screening attendance in a swiss population-based study. Cancer Epidemiol. 2015;39(6):870–6.CrossRefPubMed
21.
Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nygård M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 norwegian women. BMC Public Health. 2011;11:264.CrossRefPubMedPubMedCentral
22.
Bang JY, Yadegarfar G, Soljak M, Majeed A. Primary care factors associated with cervical screening coverage in England. J Public Health. 2012;34(4):532–8.CrossRef
23.
Shen J, Gao LL, Zhang Y, Han LL, Wang JD. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35–64 years old women who received cervical cancer screening in Beijing]. Chin J Prev Med. 2018;52(5):493–7.
24.
Niu L, Virani S, Bilheem S, Sriplung H. The effect of pap smear screening on cervical cancer stage among southern thai women. Sci Rep. 2019;9(1):16921.CrossRefPubMedPubMedCentral
25.
He J, Chen W. Chinese Cancer Registry Annual Report. Beijing: People’s Medical Publishing House; 2017.
26.
Li MD, Ni P, Yu HH, Yu ZF, Sun JX, Bai MY, Bai S, An XX, Shi YH, Liu YY. [Analysis on the status quo of the awareness rate of core knowledge of cancer prevention and treatment and its influencing factors among residents in Liaoning Province in 2021]. Chin J Prev Med. 2023;57(1):22–8.
27.
Di L. Analysis of the factors on the implementation of laws and regulations on reproductive health protection of female workers in China.Chin J Ind Hyg Occup Dis2013(02):150–152.
28.
Di J, Wang L, Li L, Tao Y, Lin Y. Rearch on implenentation of jaws and regulations of female workers health care in China.Maternal and Child Health Care of China2008(32):4522–4525.
29.
Xu H, Zhao F, Gao X, Hu S, Chen J, Liu Z, Xu X, Gao L, Liu Q, Ma L et al. Cost-effectiveness analysis on the once-in-a-lifetime cervical cancer screening program for women living in rural and urban areas of China.Chinese Journal of Epidemiology2013(04):399–403.
30.
Song B, Ding C, Chen W, Sun H, Zhang M, Chen W. Incidence and mortality of cervical cancer in China, 2013. Chin J cancer research = Chung-kuo yen cheng yen chiu. 2017;29(6):471–6.CrossRef
31.
Gu X, Zheng R, Sun K, Zhang S, Zeng H, Zhou X, Chen W, He J. Ncidence and mortality of cervical cancer in China, 2014. Chin J Oncol. 2018;40(04):241–6.
32.
Gafaranga JP, Manirakiza F, Ndagijimana E, Urimubabo JC, Karenzi ID, Muhawenayo E, Gashugi PM, Nyirasebura D, Rugwizangoga B. Knowledge, barriers and motivators to Cervical Cancer Screening in Rwanda: a qualitative study. Int J women’s health. 2022;14:1191–200.CrossRef
33.
Sun Y, Ma Y, Cao M, Hu Z, Lin W, Chen M, He Y. Breast and cervical cancer screening adherence in Jiangsu, China: an ecological perspective. Front public health. 2022;10:967495.CrossRefPubMedPubMedCentral
34.
Li Y, Ma L, Yang C, Chen Z, Zhao Y, Dang L, Lang J, Qiao Y. A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China. Chin J cancer research = Chung-kuo yen cheng yen chiu. 2019;31(5):838–48.CrossRef
35.
Kessler TA. Cervical Cancer: Prevention and early detection. Semin Oncol Nurs. 2017;33(2):172–83.CrossRefPubMed
36.
Liu T, Li S, Ratcliffe J, Chen G. Assessing Knowledge and Attitudes towards Cervical Cancer Screening among Rural Women in Eastern China.International journal of environmental research and public health2017, 14(9).
37.
Abiodun OA, Olu-Abiodun OO, Sotunsa JO, Oluwole FA. Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814.CrossRefPubMedPubMedCentral
38.
Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, et al. Cervical cancer screening policies and coverage in Europe. Eur J cancer (Oxford England: 1990). 2009;45(15):2649–58.CrossRef
Metadata
Title
A population-based cross-sectional study on the situation of cervical cancer screening in Liaoning, China
Authors
Bo Zhu
Huihui Yu
Ping Ni
Xi Chen
Jing Zhang
Danbo Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2023
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-023-02249-8

Other articles of this Issue 1/2023

BMC Women's Health 1/2023 Go to the issue

Research

Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study

Case Report

Ovotesticular disorder of sex development in a 46 XY adolescent: a rare case report with review of the literature

Research

Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute’s experience

Research

Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital NorthEast Ethiopia

Research

Inter- and intra-observer agreement in the assessment of the cervical transformation zone (TZ) by visual inspection with acetic acid (VIA) and its implications for a screen and treat approach: a reliability study

Research

“Day or night, no matter what, I will go”: Women’s perspectives on challenges with follow-up care after cervical cancer screening in Iquitos, Peru: a qualitative study